Circulatory support in infants and children

Area of Science:

• Pediatric Cardiology
• Mechanical Circulatory Support
• Cardiac Surgery

Background:

• Technological advances in mechanical circulatory support (MCS) have primarily benefited adults, with limited progress in pediatric applications.
• Intra-aortic balloon pumps have shown limited efficacy and use in children.
• Extracorporeal membrane oxygenation (ECMO) is now the primary MCS method for pediatric patients with severe cardiac failure post-operation.

Purpose of the Study:

• To review the current landscape of mechanical circulatory support devices and their application in pediatric patients.
• To highlight the efficacy and limitations of various MCS technologies in children.
• To compare pediatric MCS outcomes with adult data.

Main Methods:

• Review of current literature on pediatric mechanical circulatory support.
• Analysis of device types including ECMO, intra-aortic balloon pumps, and newer centrifugal/pneumatic devices.
• Comparison of survival rates and support durations between pediatric and adult populations.

Main Results:

• ECMO is widely used for pediatric cardiac failure, including as a bridge to transplantation or for reversible conditions like viral myocarditis.
• Newer centrifugal and pneumatic devices have shown success, particularly for isolated left ventricular support post-cardiac operations.
• Pediatric patients in myocardial recovery groups exhibit better survival rates than adults, but current devices offer limited support duration (weeks).

Conclusions:

• While ECMO and newer devices offer significant support for pediatric cardiac failure, limitations in device longevity hinder their use for bridging to transplantation.
• Pediatric MCS shows promising survival rates, especially with myocardial recovery, but requires further technological development for extended support.
• Continued innovation in pediatric mechanical circulatory support is crucial for improving outcomes and expanding therapeutic options.